ABS-0871

N/A

Report date: 2025/02/21 16:20:20
NMEFirst In Class

Base Information

Drug NameABS-0871
Drug Alias NameABS-0871
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 4 inhibitors
TargetsTransient receptor potential cation channel subfamily V member 4
Therapy Area/IndicationsCharcot-Marie-Tooth 2CUrinary Bladder, OveractiveCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesActio Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesActio Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth 2CUrinary Bladder, OveractiveCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A